TITLE

PHARMA: OTHER NEWS TO NOTE

PUB. DATE
December 2013
SOURCE
BioWorld Today;12/9/2013, Vol. 24 Issue 235, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the deal signed by Moberg Pharma AB for the acquisition of three over-the-counter drug brands in the U.S. from Bayer Healthcare LLC, in December 2013.
ACCESSION #
92958656

 

Related Articles

  • CLINIC ROUNDUP.  // BioWorld Today;12/16/2013, Vol. 24 Issue 240, p8 

    This section highlights the results of clinical trials of various medications being developed by multinational pharmaceutical companies as of December 2013. For instance, the findings of a Phase II study indicated that AcelRx Pharmaceuticals' sublingual product candidate ARX-04 was proven...

  • Moberg Derma AB: Moberg Derma Interim Report Jan - Sept 2011.  // Biomedical Market Newsletter;10/31/2011, Vol. 21, p284 

    The article reports on Moberg Derma AB's financial performance from January to September 2011. It highlights the increase of the company's net sales and improvement of its research and development (R&D) expenses, as well as operating cash flow. It also provides updates of the company's business...

  • Moberg Derma AB: Nomination Committee's Proposal to Moberg Derma's Annual General Meeting.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article informs that a general meeting will be conducted by Nomination Committee of Moberg Derma AB on April 23, 2012 for the re-election of the board members.

  • Pharma: Other News To Note.  // BioWorld Today;3/12/2013, Vol. 24 Issue 47, p9 

    The article focuses on the move of Moberg Derma AB to discontinue the development of Limtop, a formulation of imiquimod, in actinic keratosis.

  • Moberg is rolling out Kerasal Nail.  // Chain Drug Review;4/7/2014, Vol. 36 Issue 6, p9 

    The article offers brief information of the Kerasal Nail antifungal nail treatment formulation from Moberg Pharma AB.

  • Moberg Specializes in Addressing Unmet Needs in Foot Care.  // Chain Drug Review;10/27/2014 Supplement, Vol. 36, p17 

    The article evaluates the foot care product Kerasal Nail Fungal Nail Repair manufactured by Moberg Pharma.

  • Moberg to build on Balmex brand equity.  // Chain Drug Review;7/6/2015, Vol. 37 Issue 11, p35 

    The article reports that Moberg Pharma AB has acquired the Balmex diaper rash brand from consumer health product manufacturer Chattem Inc.

  • U.S. Gets New Kerasal Nail Formula.  // MMR;4/21/2014, Vol. 31 Issue 7, p30 

    The article informs that Moberg Pharma AB has started shipping its Kerasal Nail products' new formulation to the U.S. market and mentions about the firm's application for patent protection for the product.

  • Today's Transactions Bayer HealthCare to Purchase Teva's Animal Health Business for $145M. COLLINS, ALLISON // Mergers & Acquisitions Report;9/17/2012, Vol. 25 Issue 38, p35 

    The article reports that the animal health business of Teva Pharmaceutical Industries Ltd. will be acquired by Bayer HealthCare LLC.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics